Canadian Journal of Cardiology

Article	Citations
V02max Determinants Are Associated With Different Cognitive Outcomes in Women With HFrEF and HFpEF	367
UNDERSTANDING PATIENT/FAMILY PERSPECTIVES ON THE USE OF 3D PRINTED HEART MODELS OF CONGENITAL HEART DISEASE FOR FAMILY EDUCATION	68
EVALUATION OF TRANSITIONAL CARE PROCESSES FROM CARDIAC SURGERY DISCHARGE TO COMMUNITY	59
Routine Nil Per Os Before All Cardiac Catheterisations: Time to Reconsider?	41
VALIDATING ICD-10 CODES FOR IDENTIFYING OUT-OF-HOSPITAL CARDIAC ARRESTS IN AN ADMINISTRATIVE DATABASE	41
Coronary Access and PCI after Transcatheter Aortic Valve Replacement With Different Self-Expanding Platforms in Failed Surgical Valves	40
EFFECTS OF POST-MYOCARDIAL INFARCTION CARDIAC REHABILITATION ON HOSPITALIZATION RATES AND MORTALITY: A RETROSPECTIVE STUDY	39
CARDIAC CYCLE TIMING INTERVALS IN PATIENTS WITH AORTIC VALVE STENOSIS UNDERGOING TRANSCATHETER AORTIC VALVE IMPLANTATION	36
SEX-BASED DIFFERENCES IN LONG-TERM OUTCOMES FOLLOWING TRANSCATHETER CLOSURE OF PATENT FORAMEN OVALE FOR CRYPTOGENIC STROKE	35
SEX DIFFERENCES IN PLASMA LIPIDOME IN PATIENTS WITH STEMI UNDERGOING PCI	35
A NOVEL MOBILE SCREENING PROGRAM FOR VALVULAR HEART DISEASE	34
IMPROVING FAMILY ENGAGEMENT IN ACUTE CARDIOVASCULAR CARE (THE NGAGE TRIAL)	34
EDGE-TO-EDGE TECHNIQUE WITH PARTIAL BAND FOR MITRAL VALVE REPAIR COMPARED TO MITRAL REPLACEMENT FOR ISCHEMIC MITRAL REGURGITATION	33
THE INFLUENCE OF INFARCT RELATED BASELINE Q WAVES ON ECG METRICS OF REPERFUSION IN STEMI: INSIGHTS FROM THE VHR PRE-HOSPITAL STEMI REGISTRY	33
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN CANADA	33
COMMUNITY-TO-INSTITUTION ATHLETIC CARDIOVASCULAR SCREENING: VALIDATION OF AN ELECTROCARDIOGRAM WORKFLOW MODEL	32
SUPPORTIVE CARDIOLOGY: A QUALITY IMPROVEMENT PROJECT TO MEET THE GAPS IN LATE-STAGE HEART FAILURE CARE	31
IS FLAXSEED EQUIVALENT AND/OR SYNERGISTIC WITH ACE INHIBITION IN THE TREATMENT OF CHEMOTHERAPY MEDIATED CARDIOTOXICITY?	31
A PROPENSITY-MATCHED COHORT STUDY TO ASSESS THE EFFECTIVENESS OF A COMMUNITY HOSPITAL BASED HEART FUNCTION CLINIC	30
SIRT3 PREVENTS DOXORUBICIN INDUCED DILATED CARDIOMYOPATHY VIA REGULATION OF MITOCHONDRIAL PROTEIN ACETYLATION: INVESTIGATING METABOLIC DYSFUNCTION AS A RESULT OF ALTERATIONS TO CARDIAC LIPIDS	29
Safety and Efficacy of Mini-Invasive Left Atrial Appendage Closure: A Propensity-Score Analysis	28
Two Left Ventricular Pseudoaneurysms Complicating a Myocardial Infarction: The Impact of Cardiac Magnetic Resonance in the Acute Setting	27
Association of Eligibility for a Sodium-Glucose Cotransporter 2 Inhibitor and Cardiovascular Events in Patients With Atrial Fibrillation	27
Open Access Budget Impact Assessment Tools: A Welcome Step in Supporting Evidence-Informed Policy Decisions	26
Testosterone Treatment Impairs Cardiac Function and Fatty Acid Metabolism in a Rodent Model of Polycystic Ovary Syndrome	26

MUSCLE SYMPATHETIC EXCITATORY RESPONSES TO DYNAMIC ONE-LEG CYCLING EXERCISE ARE AUGMENTED IN HEART FAILURE WITH PRESERVED EJECTION FRACTION	25
EXPLORING THE GENETIC BASIS OF DYSPNEA IN INDIVIDUALS TREATED WITH TICAGRELOR: RESULTS FROM THREE CLINICAL TRIALS	25
TRIAGING REFERRALS TO ECONSULTS (TREC): PROOF OF CONCEPT	25
EVALUATION OF REAL-WORLD MANAGEMENT STRATEGIES ADOPTED IN PATIENTS WITH ATRIAL FIBRILLATION ON ANTICOAGULANTS FOLLOWING AN EPISODE OF CLINICALLY SIGNIFICANT BLEEDING	24
LOW-DOSE EMPAGLIFLOZIN AS ADJUNCT TO HYBRID CLOSED-LOOP INSULIN THERAPY IN SUB-OPTIMALLY CONTROLLED ADULTS WITH TYPE 1 DIABETES: A RANDOMIZED CROSSOVER CONTROLLED TRIAL	24
ISOLATING THE EFFECT OF A SYSTEMIC RIGHT VENTRICLE WITH BI-VENTRICULAR CIRCULATION ON CARDIORESPIRATORY FITNESS	24
The Currency of Time vs Energy: An Interventional Cardiology Fellow’s Reflections on Thriving in the Uncertainties Within Medical Training and Beyond	24
PENTRAXIN-3 AS A NOVEL CARDIOTOXIC BIOMARKER FOR BREAST CANCER PATIENTS RECEIVING ANTHRACYCLINES AND THE IMPACT OF PHYSICAL ACTIVITY: AN INTERIM REPORT FROM THE EXACT 2.0 TRIAL	23
SUICIDAL IDEATION, SUICIDE ATTEMPTS, AND SUICIDE DEATHS IN ADOLESCENTS AND YOUNG ADULTS WITH TYPE 1 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS	23
EUGLYCEMIC KETOACIDOSIS IN TYPE 1 DIABETES ON AN AUTOMATED INSULIN DELIVERY SYSTEM IMMEDIATELY AFTER BARIATRIC SURGERY: A CASE SERIES	23
An Evolving Understanding of the Basis and Management of Vascular Complications of COVID-19: Where Do We Go From Here?	23
In Memoriam: John Victor Tyberg, MD, PhD	23
Editorial Board	22
USE OF ARTS-BASED METHODS IN RESEARCH DESIGN TO ENHANCE PATIENT ENGAGEMENT	22
Screening for TMVR: A Glimpse Into the Future Technological Needs and Requirements	22
Ask What Your Society Can Do For You!	22
Decoding Long Noncoding RNAs in Myocardial Infarction: A Step Closer to a "Magic Bullet"?	22
GENETIC TESTING IN MONOGENIC EARLY-ONSET ATRIAL FIBRILLATION	22
Interatrial Shunt Therapy: A Rescue Option for Nonoperable Mitral Valve Disease Patients	21
Linking Plasma LTBP-2 Levels and Clinical Outcomes in Patients With Dilated Cardiomyopathy	21
From Improving Survival to Cost Savings for the Health System—Remote Monitoring for All?	21
P157 IMPACT OF ADMISSION TIMING ON MANAGEMENT AND IN-HOSPITAL OUTCOMES IN ACUTE HEART FAILURE: INSIGHTS FROM THE CAN-HF REGISTRY	21
Assisted Reproductive Technology and Cardiovascular Outcomes in Parents and Offspring	21
Table of Contents	21
P188 CANADIAN TRANSTHYRETIN CARDIAC AMYLOIDOSIS IMAGING AND DIAGNOSTIC CONCEPT SURVEY STUDY (CAN-TACTICS STUDY): A STANDALONE INTERVIEW STUDY	19
P338 QUIESCENCE STUDY OF VALVULAR INTERSTITIAL CELLS ISOLATED FROM HUMAN STENOSED AORTIC VALVE	18
P140 ASSOCIATION BETWEEN DISCHARGE TIMING AND DISCHARGE QUALITY AND DISPOSITION IN ACUTE HEART FAILURE	18
P359 LONG-TERM OUTCOMES OF ACUTE KIDNEY INJURY IN PATIENTS WITH TYPE B AORTIC DISSECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS	18
P251 COVID-19 VACCINATION UPTAKE AND MYOCARDITIS/PERICARDITIS COMPLICATIONS AMONG CHINESE AND SOUTH ASIANS IN ONTARIO	18
P220 TRANSCATHETER AORTIC VALVE EXPLANTS: CALCIFICATION PATTERNS AND LEAFLET THICKENING TO INFORM REPEAT INTERVENTIONS	18
Table of Contents	18
Editorial Commentary to Medical Management for Patients 90 Years Old and Up After Acute Coronary Syndrome---Never Too Old	17
The Dynamic Nature of the Socioeconomic Determinants of Cardiovascular Health: A Narrative Review	17
Myocarditis and Pericarditis After mRNA COVID-19 Vaccination: 2024 Status and Management Update	17
Assay Precision and Risk of Misclassification at Rule-Out Cutoffs for High-Sensitivity Cardiac Troponin	16
Information for Readers	16
Does Remote Work Promote Exercise and Cardiovascular Health? Current Evidence and Future Directions	16
Catheter Ablation of Atrial Arrhythmias in Patients Post-Fontan	16
Does Higher Temperature During Moderate Hypothermic Circulatory Arrest Increase the Risk of Paraplegia in Acute DeBakey I Aortic Dissection Patients?	16
Reducing Cardiovascular Risk: The Potential of Plant-Based Meat Alternatives and Egg Substitutes	16
Hemoglobin, Frailty, and Long-term Cardiovascular Events in Community-Dwelling Older Men Aged ≥ 70 Years	15
Age-Dependent Relationship of Physical Inactivity With Incident Cardiovascular Disease: Analysis of a Large Japanese Cohort	15
Utility of Substrate Mapping Using Extrasystole to Localise Comprehensive Ventricular Tachycardia Circuits: Results From Intra-operative Mapping Studies	15
Reply to Pendyal—Long-term Adverse Outcomes in Black Women With Obstructive Coronary Artery Disease: A Study of the Women’s Ischemia Syndrome Evaluation (WISE) Cohort	14
Beta-Blockers, Digoxin, or Both Following an Incident Diagnosis of Atrial Fibrillation: A Prospective Cohort Study	14
Transcatheter Mitral Valve-in-Ring Implantation: Not All Rings Are the Same	14
Racial and Ethnic Disparities in Primary Prevention of Cardiovascular Disease	14
Coronary Angiography–Derived Index of Microcirculatory Resistance Associated With New-Onset Atrial Fibrillation in Patients With STEMI	14
Mechanical Circulatory Support for Septic Shock in Children and Adults: Different But Similar	14
A Simple Score to Predict New-Onset Atrial Fibrillation After Ablation of Typical Atrial Flutter	14

Effect of Life’s Essential 8 and Exposure to Solid Fuels for Cooking on Cardiovascular Disease Risk	14
Editorial Commentary to The RV Puzzle: How Electromechanical Dyssynchrony Shapes Outcomes in Patients With Tetralogy of Fallot	14
Optimizing Care Pathways in Infective Endocarditis: No One Should Be Left Alone	14
NDRG1 Regulates Iron Metabolism and Inhibits Pathologic Cardiac Hypertrophy	14
ROLE OF SEX AND GENDER IN DEVELOPMENT OF METABOLIC SYNDROME: A PROSPECTIVE COHORT STUDY	14
Integrating Life’s Crucial 9 and Polygenic Risk Scores into Atrial Fibrillation Prevention	14
Real-World Treatment of In-Stent Restenosis: The Return of the Balloon	13
Renalism with Renin Angiotensin Aldosterone System Blockade: What Is the Consensus in Advanced Chronic Kidney Disease?	13
The Pericardial Space: Can It Be Leveraged for Diagnostic, Prognostic, and Therapeutic Purposes?	13
Ventricular Tachycardia Burden and Mortality: Association or Causality?	13
OUTCOMES AND PREVALENCE OF SUBCLINICAL ATRIAL FIBRILLATION IN HEART FAILURE PATIENTS	13
The Continuing Scourge of Atherosclerotic Cardiovascular Disease: Importance of Multidisciplinary and Innovative Person-Centred Approaches	13
Environmental Health and Access to Cardiovascular Care: Mutually Exclusive or a Hidden Opportunity?	13
Three-Dimensional Imaging of the Left Atrium and Adjacent Structures With the Use of Artificial Intelligence and Intraoperative Echocardiography	13
PREDICTORS OF HIGH PACING PERCENTAGE IN PATIENTS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT	13
ASSESSMENT OF VARIABILITY IN THE ECHO-DOPPLER MEASUREMENT OF AORTIC PULSE WAVE VELOCITY	13
Invited Commentary: Beyond the Waveform: Artificial Intelligence–Enhanced Electrocardiogram for Left Ventricular Ejection Fraction Prediction	13
Announcement: Call for Original Papers: Focus Issue on Circulatory Support and Shock Management	13
Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Cardiomyopathy With Residual Obstruction After Alcohol Septal Ablation	13
Call for Original Papers: Focus Issue on Obesity	13
Optimizing Energy Delivery in Cardioversion: A Randomized PROTOCOLENERGYTrial of 2 Different Algorithms in Patients With Atrial Fibrillation	12
Postprocedural Parenteral Anticoagulation in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes	12
New Developments in Continuous Hemodynamic Monitoring of the Critically Ill Patient	12
IDENTIFYING SOCIAL FACTORS THAT MAY LIMIT EARLY DISCHARGE IN LOW-RISK ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION	12
CCC Author Index	12
Retrograde Scratch-and-Go for Chronic Total Occlusion Percutaneous Coronary Intervention	12
Beyond NT-ProBNP: Circulating Protein Biomarkers for Atrial Fibrillation in Heart Failure and Cardiomyopathy	12
Comprehensive Prevention of Exercise-Related Sudden Cardiac Arrest or Death	12
Integrating the Care of Metabolic Dysfunction–associated Steatotic Liver Disease Into Cardiac Rehabilitation: A Multisystem Approach	12
SODIUM-GLUCOSE TRANSPORT PROTEIN 2 INHIBITOR ELIGIBILITY FOR PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE	12
Prognostic Role of Right Atrial Reservoir Strain in Acute Heart Failure	12
Resuscitative Hysterotomy and Maternal and Neonatal Mortality in Maternal Cardiac Arrest Patients---a Systematic Review and Meta-analysis	12
The Impact of Transcatheter Aortic Valve Implantation on Health Care Costs and Clinical Outcomes Based on Frailty Risk: A Nationwide Cohort Analysis	12
Association Between Electrocardiographic Changes and Myocardial Injury or Death After Cardiac Surgery	12
Invited commentary on the importance of endothelial TRPV4 ion channel in myocardial ischemia-reperfusion	12
RESETTING THE BAR: INCREASING CARDIOVASCULAR REHABILITATION ENROLLMENT IN A TERTIARY CARDIAC CARE SETTING	12
Unique Challenges in Pediatric Heart Transplantation	12
DIRECT TRANS-ATRIAL IMPLANTATION OF SAPIEN 3 VALVE FOR MITRAL ANNULAR CALCIFICATION: MULTI CENTER EXPERIENCE	11
CJCA_ANN_Call for Original Papers - Gene-based Therapies	11
FRAIL-AF Study: More Bleeding With DOACs Compared With VKAs in Patients With Frailty?	11
GENETIC TESTING FOR FAMILIAL HYPERCHOLESTEROLEMIA IN THE PROVINCE OF QUÉBEC: A SINGLE CENTER RETROSPECTIVE COHORT STUDY	11
P277 THE RELATIONSHIP BETWEEN CARDIORESPIRATORY FITNESS AND COGNITION IN WITH CARDIOVASCULAR RISK FACTORS, CORONARY DISEASE AND HEART FAILURE	11
P119 IMPACT OF WAIT-TIMES FOR ATRIAL FIBRILLATION ABLATION ON CUMULATIVE HEALTHCARE COSTS	11
Pacemaker Risk Stratification in Patients With Pre-existing Right Bundle Branch Block Undergoing Transcatheter Aortic Valve Replacement	11
The Fontan Fenestration: What Are Its Long-term Implications?	11
A New Kid on the Block in the Rapidly Evolving Landscape of Intravascular Lithotripsy: Novel Technologies for Challenging Calcified Coronary Lesions	11
Mitral Transcatheter Edge-to-Edge Repair in Nonagenarians	11
Recognizing the Risks to Women for Cardiovascular Disease: A Quality Initiative in the Cardiac Imaging Program at the University of Ottawa Heart Institute (UOHI)	11
P332 PREDICTORS OF QUALITY OF LIFE IN PATIENTS WITH VASOVAGAL SYNCOPE: A CROSS-SECTIONAL STUDY	11
P199 NON-INVASIVE MYOCARDIAL WORK AFTER PEDIATRIC ORTHOTOPIC HEART TRANSPLANTATION: FUNCTIONAL RECOVERY AND IMPLICATIONS OF ACUTE CELLULAR REJECTION	11
Engaging Women With Lived Experience in Tailoring Educational Resources for Cardiovascular Rehabilitation	11
ECHOCARDIOGRAPHIC EVALUATION OF LEFT VENTRICULAR REMODELING AFTER VALSARTAN/SACUBITRIL INITIATION IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION	11
SINGLE CENTRE COMPARISON OF PATIENTS MANAGED BY A CODE SHOCK TEAM VERSUS STANDARD OF CARE	11
Race and Ethnicity Research in Cardiovascular Disease in Canada: Challenges and Opportunities	11
Integrative Omics Approaches in Cardiovascular Disease Research: Current Trends and Future Directions	11
P350 GENETIC TESTING IN HEART TRANSPLANT RECIPIENTS: ARE WE MISSING AN OPPORTUNITY?	11
P207 CLINICAL AND LOGISTICAL IMPACTS OF IMPLEMENTATION OF A STANDARDIZED DECISIONAL ALGORITHM FOR THE MANAGEMENT OF PERI-TAVI CONDUCTION DISTURBANCES	11
Clinical Outcomes in Younger Women Hospitalized With an Acute Myocardial Infarction: A Contemporary Population-Level Analysis	11
INVESTIGATION OF CARDIOTOXICITY OF ENGINEERED ANTIMICROBIAL PEPTIDES IN ZEBRAFISH EMBRYOS	10
Vascular Complications in Transcatheter Aortic Valve Replacement With Plug-Based vs Suture-Based Closure Devices	10
COMPLEMENT ACTIVATION IS RELATED TO CLINICAL CARDIOPULMONARY DYSFUNCTION FOLLOWING PEDIATRIC CARDIAC SURGERY WITH CONTINUOUS ULTRAFILTRATION	10
ALLEVIATION OF CARBOHYDRATE COUNTING IN TYPE 1 DIABETES WITH AUTOMATED FASTER ASPART AND PRAMLINTIDE CLOSED-LOOP DELIVERY (ARTIFICIAL PANCREAS): A RANDOMIZED CONTROLLED TRIAL	10
Table of Contents	10
Jigging our Health: Cardiovascular Benefits of a Red River Jigging Intervention for Saskatchewan Females	10
Therapy in Pediatric Pulmonary Hypertension: Memoir of an Unfinished Journey	10
FOOD LABELS MATTER IN DIABETES: A NUTRITIONAL ANALYSIS OF PRODUCTS MARKETED AS PLANT-BASED ACROSS THE UNITED STATES, UNITED KINGDOM, AND CANADA	10
Atrial Fibrillation Detection by Smartwatch Devices in Patients With Underlying ECG Abnormalities: Still Not Smart Enough?	10
New Resource: Heart Failure Medications: A Patient and Caregiver Guide	10
TWO-YEAR OUTCOMES IN AN EXPANDED COHORT OF HARMONY TRANSCATHETER PULMONARY VALVE RECIPIENTS	10
Perception of Cardiovascular Risk in Familial Hypercholesterolemia According to Sex	10
The Climate-Smart Cardiologist: Incorporating Environmental Cardiology Into Medical Education	10
A LEADLESS VENTRICULAR PACEMAKER PROVIDING ATRIOVENTRICULAR SYNCHRONOUS PACING IN THE REAL-WORLD SETTING: RESULTS FROM THE MICRA AV POST-APPROVAL REGISTRY	10
IMPLEMENTATION OF A SPECIALIZED HEART FUNCTION INPATIENT UNIT TO OPTIMIZE PATIENT CARE AND STAFF/LEARNER SATISFACTION	10
Epidemiology of Resistant Hypertension in Canada	10
Cerebral Embolic Protection Device During Transcatheter Mitral Valve-in-Valve Implantation in a Patient With Left Atrial Appendage Thrombosis	9
Announcement: Call for Papers: Focus Issue on Advances in Understanding and Managing the Cardiovascular Complications of COVID-19	9
CJCA_ANN_Call for Original Papers_Endo	9
Chronic Pericardial Effusion: Causes and Management	9
Editorial Board	9
Clinical Outcomes of Percutaneous Fontan Stenting in Adults	9

The Emerging Role of Combined Transcatheter Multivalve Interventions---A Mini-review	9
The Residual Lipid-Rich Coronary Atheroma Behind the Implanted Newer-Generation Drug-Eluting Stent and Future Stent-Related Event Risks	9
Neurologic Complications in Patients With Left Ventricular Assist Devices	9
Editorial Commentary to Mapping the Monogenic and Polygenic Architecture of Mitral Valve Prolapse	9
Smartphones and the Smart Heart: Balancing the Risks and Benefits of Mobile Devices in Disease Prevention	9
Revolutionising Acute Cardiac Care With Artificial Intelligence: Opportunities and Challenges	9
Canadian Society of Clinical Chemists Harmonized Clinical Laboratory Lipid Reporting Recommendations on the Basis of the 2021 Canadian Cardiovascular Society Lipid Guidelines	9
BASILICA Technique for Prevention of Coronary Artery Occlusion in High-Risk Native Transcatheter Aortic Valve Replacement	9
The Interpretation of Toxicology Screening Tests for Substances With Abuse Potential: A Primer for the Cardiovascular Specialist	9
The Link Between Mobile Phone Use and Cardiovascular Disease: A Call for Greater Attention	9
Information for Readers	9
CJCA_ANN_Call for Original Papers_Endo	9
Novel Artificial Intelligence Applications in Heart Transplantation	9
Editorial Commentary to Uncovering Early Irreversible Cardiac Damage in Patients With Fabry Disease: Getting to the Heart of It	9
P205 ASSESSMENT OF BLEEDING RISK AMONG PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH DRUG-ELUTING STENTS FOR ACUTE CORONARY SYNDROME AT CHUS IN 2023	8
TWENTY-YEAR OUTCOMES FOLLOWING PORCINE VERSUS PERICARDIAL AORTIC VALVE REPLACEMENT	8
P027 SAFETY OF PUMP-CONTROLLED RETROGRADE TRIAL OFF (PCRTO) FOR WEANING FROM VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION IN ADULTS	8
BENZODIAZEPINE-FREE CARDIAC ANESTHESIA FOR REDUCTION OF POSTOPERATIVE DELIRIUM: A PRAGMATIC CLUSTER-RANDOMIZED CROSSOVER TRIAL	8
P311 IMPACT OF ASSISTED REPRODUCTIVE TECHNOLOGIES IN WOMEN WITH CARDIOVASCULAR DISEASE	8
The Pursuit of Health Equity in Cardiovascular Care: From Research to Practice	8
President’s Page	8
P363 ASSOCIATION OF COVID-19 VACCINATION TO CLINICAL OUTCOMES IN PATIENTS WITH MYOCARDIAL INFARCTION	8
P217 PERI-PROCEDURAL AND FOLLOW-UP OUTCOMES WITH LEFT ATRIAL APPENDAGE CLOSURE AND SAME-DAY DISCHARGE	8
Challenges in the Evaluation of Aortic Stenosis: A Guide to Multimodal Imaging	8
Refining the Stratification and Prognosis of Cardiogenic Shock Patients to Improve Their Outcome	8
ONE-YEAR OUTCOMES OF K-CLIP TRANSCATHETER ANNULAR REPAIR FOR PATIENTS WITH SEVERE ATRIAL FUNCTIONAL TRICUSPID REGURGITATION	8
P201 SYNTHETIC T1 MAP GENERATION USING R-GAN FOR NON-CONTRAST MYOCARDIAL FIBROSIS DETECTION	8
Evolution in Trends of Primary Lower-Extremity Amputations Associated With Diabetes or Peripheral Artery Disease From 2006 to 2019	8
IMPACT OF TRANSCATHETER AORTIC VALVE IMPLANTATION ON CIRCULATING VON WILLEBRAND FACTOR IN PATIENTS WITH SEVERE AORTIC STENOSIS	8
P259 FAMILIAL HYPERCHOLESTEROLEMIA IN CANADA: SEX DIFFERENCES IN DIAGNOSIS, MANAGEMENT AND OUTCOMES FROM THE FH CANADA REGISTRY	8
Invasive Management of Hypertrophic Cardiomyopathy With Clinically Important Obstruction: Surgical Myectomy Is Superior, but Only When Accessible	8
VIRTUAL PEER-TO-PEER MENTORING FOR ADOLESCENTS WITH CONGENITAL HEART DISEASE: AN IMPLEMENTATION STUDY	8
P229 THE IMPLEMENTATION OF A POST-DISCHARGE CLASS FOR PATIENTS WITH SPONTANEOUS CORONARY ARTERY DISSECTION (SCAD): A BRIDGE TO FURTHER CARDIAC CARE	8
REMOTE PATIENT MONITORING AND DIGITAL THERAPEUTICS IN HEART FAILURE: IMPACT ON COSTS AND CLINICAL OUTCOMES	8
Editorial Commentary to The Role of Myocardial Radiofrequency Ablation in the Management of Obstructive Hypertrophic Cardiomyopathy	8
OVULATORY AND ANOVULATORY CYCLE PHASE INFLUENCES ON QT INTERVAL DYNAMICS DURING MENSTRUAL CYCLES	8
Capturing Pregnancy History in the Electronic Medical Record: An Opportunity to Improve Women's Future Cardiovascular Health	8
P004 BENCHMARKING NSTEMI CATH-TO-CABG TIMES IN BRITISH COLUMBIA	8
Information for Readers	8
A FUNCTIONAL ASSAY TO QUANTIFY THE HEMOSTATIC PROPERTIES OF STIMULATED PLATELETS	7
ROLE OF MEDICAL THERAPY TO REDUCE THE RATE OF AORTIC DILATATION IN CHILDREN WITH BICUSPID AORTIC VALVE	7
VARIOUS COMBINATIONS OF GESTATIONAL DIABETES AND GESTATIONAL HYPERTENSION IN TWO PREGNANCIES AND ASSOCIATIONS WITH CARDIOVASCULAR DISEASE	7
CASE REPORT: UNCONTROLLED HYPERTHYROIDISM IN PREGNANCY ASSOCIATED WITH FETAL HEART MALFORMATION	7
Impact of High-Sensitivity Cardiac Troponin I Elevation After On- and Off-Pump Coronary Artery Bypass Grafting on Long-Term Prognosis	7
Value of the 6-Minute Walk Test for Risk Assessment in Patients With Hypertrophic Cardiomyopathy	7
Abdominal-only Compression Garments Reduce Orthostatic Tachycardia and Improve Symptoms in Patients With Postural Orthostatic Tachycardia Syndrome	7
Nonfungible Tokens in Cardiovascular Medicine	7
Myocardial Involvement Is Just as Common in Patients Hospitalised for Influenza as in Those Hospitalised for Covid-19: Insights From the GEMINI Initiative	7
Information for Readers	7
Sodium-Glucose Cotransporter 2 Inhibitor Among Patients With Cancer Therapy–Induced Left Ventricular Dysfunction	7
THE DIRECT AMPK-β1 SELECTIVE ACTIVATOR PF-06409577 TARGETS MACROPHAGES TO REDUCE ATHEROSCLEROSIS IN MICE	7
Determinants and Clinical Outcomes of Patients With Tetralogy of Fallot Lost to Cardiology Follow-up	7
AN INCREASED RATIO OF EICOSAPENTAENOIC ACID (EPA) TO ARACHIDONIC ACID (EPA/AA) REDUCED INFLAMMATORY CHANGES IN VASCULAR ENDOTHELIUM	7
Quality of Life and Other Patient-Reported Outcomes Across the Life Span Among People With Fontan Palliation	7
Information for Readers	7
Vascular Health in Congenital Heart Disease: A Systematic Review and Meta-Analysis	7
RESHAPE-HF2 Trial: Are We Overestimating the Benefits of MitraClip in Elderly Patients with Functional Mitral Regurgitation?	7
Unique Aspects of Hypertrophic Cardiomyopathy in Children	7
LOW DENSITY NEUTROPHILS ARE NEW INFLAMMATORY PLAYERS IN HEART FAILURE: ROLE OF NEUTROPHIL EXTRACELLULAR TRAPS (NETS)	7
Environmental Considerations in the Daily Practice of Cardiovascular Medicine	7
Barriers to Guideline-Directed Anticoagulation in Patients With Atrial Fibrillation: New Approaches to an Old Problem	7
SAFETY OF CONTINUING AMIODARONE DOSING IN PATIENTS MANAGED WITH METHIMAZOLE FOR HYPERTHYROIDISM ASSOCIATED WITH THE IODINE LOAD RELEASED FROM AMIODARONE METABOLISM: A CASE SERIES	7
Outcomes of Severe Mitral Stenosis With the Revised Severity Criteria: Mitral Valve Replacement vs Percutaneous Mitral Valvuloplasty	7
CJCA_ANN_Call for Original Papers_Endo	7
Left Atrial Appendage Closure in Patients With a Mechanical Mitral Valve Prosthesis: A Multicentre Italian Pilot Study	7
Benefits of Cardiac Rehabilitation Programs, Physical Exercise, and Cognitive Training on Cognitive Deficits in Cardiovascular Diseases	7
Explainable Artificial Intelligence–driven Risk Assessment for Malignant Ventricular Arrhythmia and Mortality in Acute Myocardial Infarction	7
Air Pollution and Arrhythmias	7
ASSOCIATIONS BETWEEN ANEMIA AND CLINICAL OUTCOMES IN CARDIAC AMYLOIDOSIS	7
NOVEL ALGORITHM APPLIED IN PILOT HEART FAILURE CONTINUITY CLINIC MAY CONFER MORTALITY BENEFIT WHEN COMPARED TO USUAL CARE PATHWAY	6
INCREASED EICOSAPENTAENOIC ACID TO ARACHIDONIC ACID (EPA/AA) RATIO IN BRAIN ENDOTHELIAL CELLS ASSOCIATED WITH REDUCED EXPRESSION OF NEUTROPHIL DEGRANULATION PROTEINS DURING INFLAMMATION	6
P240 ACCESS TO CARDIAC SURGERY IN ONTARIO, CANADA: A GEOSPATIAL ANALYSIS	6
P249 CHANGES IN EATING BEHAVIORS AT 12 MONTHS AND 15 YEARS AFTER BARIATRIC SURGERY	6
A Second Chance for Survival: Clinical Trial Evidence, Eligibility, and Barriers to Implementation of ECPR for Out-of-Hospital Cardiac Arrest	6
P231 UNDERSTANDING HEALTHCARE PROVIDERS PERSPECTIVES OF EARLY MOBILITY IN THE CARDIAC SURGERY INTENSIVE CARE UNIT USING INTERPRETIVE DESCRIPTION	6
How Does the Dose and Type of Exercise Impact Acute Cardiovascular Function in Healthy Individuals?	6
Editorial Board	6
SEX-RELATED DIFFERENCES AND THE INFLUENCE OF PREGNANCY ON CARDIAC OUTCOMES IN ADULTS WITH A SYSTEMIC RIGHT VENTRICLE AND BIVENTRICULAR PHYSIOLOGY	6
EVALUATION OF WRITTEN MEDICATION EDUCATIONAL RESOURCES FOR PEOPLE LIVING WITH HEART FAILURE	6
MEASURING WITH MEANING: PATIENTS' PERSPECTIVE ON SELF-MONITORING OF BLOOD PRESSURE VIA VIRTUAL VISIT	6
P164 OPTIMIZATION OF GUIDELINE-DIRECTED MEDICAL THERAPY DURING HOSPITALIZATION FOR PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION	6
YAP Facilitates NEDD4L-Mediated Ubiquitination and Degradation of ACSL4 to Alleviate Ferroptosis in Myocardial Ischemia-Reperfusion Injury	6
TIRZEPATIDE REDUCES ALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES: POST HOC POOLED ANALYSIS OF SURPASS-1 to -5	6
When Bad Things Happen to Good Hearts Prediction and Management of Primary Graft Dysfunction	6
Outcomes of Focal Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia	6
Coronary Periarteritis in Immunoglubulin G4-Related Disease: Imaging and Regression of Tumour-Like Masses	6
Estimated Aortic Pulse Wave Velocity Is Associated With Faster Thoracic Aortic Aneurysm Growth: A Prospective Cohort Study With Sex-Specific Analyses	6
Frailty May Blunt the Therapeutic Efficacy and Complication Risk Through Multipronged Mechanisms—REPLY	6
P279 ADVERSE REACTIONS TO INTRAVENOUS IRON: INCIDENCE, PREDICTORS, AND MANAGEMENT IN A TERTIARY CARE CENTER	6
P345 THE EFFECTS OF THE ACTIVE STAND TEST ON THE CARDIOPULMONARY HEMODYNAMIC RESPONSES IN HEALTHY ADULTS	6
Sex and Gender Determinants of Vascular Disease in the Global Context	6
Recent Advances in Infective Endocarditis; When and How to Transition to Oral Antibiotic Treatment	6
Common Cardiac Implantable Electronic Device Issues Encountered by Cardiology Trainees	6
The Challenges of Contemporary Atherosclerotic Cardiovascular Disease Management	6
Table of Contents	6